Remdesivir

Remdesivir is a novel antiviral drug in the class of nucleotide analogs. It was developed by Gilead Sciences and as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and the coronaviruses. It is being studied for SARS-CoV-2 and Nipah and Hendra virus infections. Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, infected with SARS-CoV-2 and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms.


Remdesivir is a novel antiviral drug in the class of nucleotide analogs. It was developed by Gilead Sciences and as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and the coronaviruses. It is being studied for SARS-CoV-2 and Nipah and Hendra virus infections. Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, infected with SARS-CoV-2 and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms.
Read article on Wikipedia

Remdesivir

Remdesivir es un medicamento antiviral, un nuevo profármaco usado por por primera vez en 2009, que pertenece al grupo de los análogos de nucleótidos. La vía de administración es mediante inyección intravenosa y oral en infusión. Actualmente, se encuentra en estudios experimentales con pacientes con COVID-19, no obstante su uso incrementa el riesgo de daño a los riñones.


Remdesivir es un medicamento antiviral, un nuevo profármaco usado por por primera vez en 2009, que pertenece al grupo de los análogos de nucleótidos. La vía de administración es mediante inyección intravenosa y oral en infusión. Actualmente, se encuentra en estudios experimentales con pacientes con COVID-19, no obstante su uso incrementa el riesgo de daño a los riñones.
Read article on Wikipedia